Drugs / Kuntai Capsule
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT05021094 | Oct 2021 → Dec 2023 | primary ovarian failure | Affiliated Hospital of Nantong University | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Kuntai Capsule | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05021094 ↗ |
| Route | Oral | “the usage of Kuntai capsule is oral taking 4 capsules each time” NCT05021094 ↗ |